Lenvagen-10
| Packed: |
10 mg / 30 Capsules |
|---|---|
| Manufacturer: |
Hetero Labs Limited |
| Active ingredient: |
Lenvatinib Capsules IP 4 mg |
Progressive locally advanced or metastatic differentiated (papillary, follicular, with Gurtle cells) thyroid carcinoma that is refractory to radioactive iodine.
In combination with everolimus for the treatment of advanced renal cell carcinoma after one prior course of targeted therapy with vascular endothelial growth factor receptor inhibitors.
